期刊文献+

糖皮质激素在肾脏疾病中的规范性应用

Standard application of glucocorticoid to kidney disease
下载PDF
导出
摘要 肾脏疾病的发生、发展大多与免疫异常有关,免疫调节或免疫抑制是治疗肾脏疾病的基础方法,糖皮质激素(glucocorticoid,GC)是治疗免疫性肾脏疾病的主要药物,具有强大的抗炎和免疫抑制作用,在肾脏病临床治疗中应用甚广。但其种类繁多,使用不当会造成严重的不良反应,必须严格掌握其适应证,并规范GC的临床使用。本文重点介绍GC的临床药理、适应证、禁忌证和不良反应等。 The occurrence and development of kidney diseases are mostly related to immune disorders, Immunological regulation or immunosuppression is the basic therapies for kidney diseases, in which glucocorticoid is mainly used for its great anti-inflammatory and immunosuppressive action. Because of the various types and many side effects of glucocorticoids, it is necessary to restrict the indication and standardize the application of glucocorticoids to kidney disease. This article aims to discuss clinical pharmacology , indication, contraindication and adverse reactions of glucocorticoids.
出处 《实用医院临床杂志》 2008年第4期19-21,共3页 Practical Journal of Clinical Medicine
关键词 糖皮质激素 肾脏病 规范治疗 Glucocorticoids Kidney disease Standard treatment
  • 相关文献

参考文献9

  • 1刘伏友,彭佑铭.甲基强的松龙冲击疗法临床应用体会[J].肾脏病与透析肾移植杂志,2002,11(5):440-441. 被引量:10
  • 2[2]Shashank R,Jurgen B,Helmut M,et al.Pharmacokinetics of methyl-prednisolone and prednisolone after single and multi-oral administration[J].J Clin Pharmacol,1997,37(3):916-925.
  • 3[3]David C.Pharmacokinetics and pharmacodynamics of systemically admin-istered glucocorticlids[J].Clin Phannacokinet,2005,44(1):61-98.
  • 4[4]Hirano T,Oka K,Takeuehi H.A comparison of prednisolone and methyl-prednisolone for renal transplantation[J].Clin Transplantation,2000,14(4 Pt 1):323-328.
  • 5[5]Korbet SM,Schwartz MM,Lewis E J,Primary focal segmental glomerulo-sclerosis:Clinical course and response to therapy[J].Am J Kidney Dis,1994,23(6):773-783.
  • 6[6]Ponticelli C,Villa M,Banff G,et al.Can prolonged treatment improve the prognosis in adult with focal segmental glomerulosclerosis[J].Am J Kid-ney Dis,1999,34(4):618-625.
  • 7[7]Bolton KW,Sturgill BC.Methylpredniselone therapy for acute crescentic rapidly progressive glomerulonephritis[J].Am J Nephrol,1989,9(5):368-375.
  • 8[8]Buttgereit F,Wehling M,Burmester GR.A new hypothesis of modular glu-cocorticoid actions.Steriod treatment of rheumatic diseases revisted[J].Arthritis Rheum,1998,41(5):761-767.
  • 9[9]Jayne DR,Rasmussen N.Treatment of antineutrophil cytoplasm autoanti-body-associated systemic vasculitis:initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group Mayo[J].Clin Proc,1997,72(8):737-747.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部